Eye Diseases
📧 Sign up to get email alerts when something new happens for Eye Diseases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Correlation Between Exhaled Propofol Concentration With Plasma Concentration in Children [NA]
A completed clinical trial evaluated the relationship between exhaled propofol concentration and plasma concentration in pediatric patients …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Assessment of the Ocular Microbiome in Health and Disease
This Vanderbilt-led clinical trial assesses the ocular microbiome in health and disease and is currently recruiting participants.
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis [EARLY_Phase 1]
A Phase 1 safety and efficacy study of IVB102 for X-linked retinoschisis is registered and currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Precision Diagnosis and Therapy for Rare Diseases by Interpreting Non-coding Genomes
A clinical trial exploring precision diagnosis and therapy for rare diseases by interpreting non-coding regions of the genome.
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Multimodal Machine Learning for Auxiliary Diagnosis of Eye Diseases
Clinical trial evaluating multimodal machine learning for auxiliary diagnosis of eye diseases has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Effectiveness of Periocular Drug Injection in CATaract Surgery [Phase 3]
Phase 3 trial evaluating periocular drug injection in cataract surgery was terminated; the update does not provide final results.
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: Abatacept in Patients With Birdshot HLA A29 Uveitis [Phase 2]
Phase 2 clinical trial evaluating abatacept in patients with Birdshot uveitis (HLA-A29 positive). Completed.
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE) [Phase 2, Phase 3]
A clinical trial evaluating efficacy, safety, tolerability, and exposure of repeat-dose Sepofarsen (QR-110) in Leber Congenital Amaurosis 10…
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: Collagen Cross-Linking With Ultraviolet-A in Asymmetric Corneas [Phase 2]
Phase 2 trial investigating collagen cross-linking with UVA in asymmetric corneas (keratoconus) was terminated with results posted in 2022.
-
EMA withdrawal · 2021-03-19EMA Application withdrawn: Dexamethasone Taw (Dexamethasone (sodium phosphate)) — Taw Pharma (Ireland) Ltd
EMA withdrew the application for Dexamethasone Taw (dexamethasone sodium phosphate) by Taw Pharma (Ireland) Ltd.
-
CLINICAL_TRIALS research · 2018-07-16Clinical Trial Update: Shanghai Children and Adolescent Diabetes Eye Study
A clinical trial in Shanghai is recruiting children and adolescents to study diabetes-related eye conditions.
-
FDA approval · 2017-12-14FDA Approved: ALTAFLUOR — Original Application (Altaire Pharmaceuticals Inc.)
FDA approved AltaFluor, an ophthalmic solution combining fluorescein sodium with benoxinate hydrochloride, under an original application.
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Pharmacokinetics of Trans-resveratrol Based Nutritional Supplement and Its Three Metabolites in Human Eyes and Blood [NA]
This clinical trial update investigates the pharmacokinetics of a trans-resveratrol–based nutritional supplement and its three metabolites i…
-
EMA withdrawal · 2013-08-06EMA Application withdrawn: Raxone (idebenone) — Santhera Pharmaceuticals (Deutschland) GmbH
EMA indicates that the application for Raxone (idebenone) has been withdrawn by the applicant.
-
CLINICAL_TRIALS research · 2012-12-27Clinical Trial Update: Patient Specific Induced Pluripotency Stem Cells (PSiPS)
This clinical trial update reports completion of a study using patient-specific induced pluripotent stem cells (PSiPS) to address liver dise…